Episode 473: LIVE from ILADS: Nicole Bell - Transforming Lyme Disease Diagnostics

In This Episode: Nicole Bell, CEO of Galaxy Diagnostics, shares her journey from personal experience with Lyme disease in her family to leading innovation in diagnostics. The connection between tick-borne pathogens and chronic diseases like early-onset Alzheimer’s. Why traditional Lyme disease tests often fail and the need for direct detection methods. The latest advancements in testing for Borrelia, Bartonella, Babesia, and other stealth pathogens. The impact of Nicole’s "State of Lyme Disease Research" report on the Lyme community. What patients and healthcare providers need to know about cutting-edge diagnostic tools. Why This Matters: An increasing number of studies link flea- and tick-borne pathogens to chronic illnesses affecting the joints, heart, and central nervous system. These infections mimic conditions like lupus and fibromyalgia, making them hard to diagnose without advanced testing. Galaxy Diagnostics offers specialized tests to detect Lyme Borrelia, Bartonella, Babesia, Anaplasma, Ehrlichia, and Rickettsia species—providing a much-needed solution for patients seeking accurate diagnoses. Resources & Links: 🔗 Follow the latest ILADS updates at ILADS.org 🔬 Learn more about Nicole Bell and Galaxy Diagnostics: www.galaxydx.com 📲 Stay connected with Tick Boot Camp: Website | Instagram | Facebook | YouTube | TikTok | Twitter (X)